[Role of Rheb in Human Acute Myeloid Leukemia]

Xiao-Min Wang1, Qiao-Zhu Xu1, Ya-Nan Gao1

  • 1State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 30020, China.

Abstract

Insights

Low Rheb expression indicates a poor prognosis in acute myeloid leukemia (AML) patients, correlating with splenomegaly and reduced sensitivity to Ara-C treatment. Conversely, higher Rheb levels are linked to better survival outcomes.

Area of Science:

  • Hematology
  • Oncology
  • Molecular Biology

Background:

  • Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy.
  • The role of Rheb, a Ras homologue and mTOR activator, in AML pathogenesis requires further elucidation.

Purpose of the Study:

  • To investigate the prognostic significance of Rheb expression in adult AML patients.
  • To determine the association between Rheb levels and clinical characteristics, including survival and response to chemotherapy.

Main Methods:

  • Quantitative real-time PCR was used to measure Rheb mRNA levels in bone marrow samples from 27 AML patients and 29 controls.
  • Correlation analysis was performed to assess the relationship between Rheb expression and clinical parameters.
  • In vitro studies using the HL-60 AML cell line evaluated the impact of Rheb overexpression on cell proliferation and sensitivity to Ara-C.

Main Results:

  • Rheb mRNA levels in AML patients were comparable to controls.
  • Lower Rheb expression was associated with splenomegaly and poorer patient survival.
  • Overexpression of Rheb in HL-60 cells enhanced sensitivity to Ara-C treatment and promoted apoptosis.

Conclusions:

  • Reduced Rheb expression serves as a poor prognostic biomarker in AML.
  • Low Rheb levels are linked to splenomegaly and chemoresistance, particularly to Ara-C.
  • Targeting Rheb or understanding its pathway may offer therapeutic strategies for AML.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.9K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.6K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.9K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.5K
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
4.2K